ACTRN12622001434785终止未知
Maintaining Remission of Ulcerative Colitis with Faecal Microbiota Transplantation: the MR-UC-FMT Trial
Central Adelaide Local Health Network0 个研究点目标入组 36 人开始时间: 2022年11月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Patients aged 18 - 75 years
- •Formal diagnosis of UC for greater than or equal to 1 month
- •Currently under the care of a gastroenterologist
- •Mild to Moderately Active UC with Total Mayo score 3 to 10 inclusive.
- •Mayo Endoscopic Sub Score greater than or equal to 2 (to ensure symptoms are due to UC and not due to a concurrent functional bowel disorder)
排除标准
- •Severe UC with Total Mayo score of greater than or equal to 11 or by Truelove Witts Criteria
- •Diminished mental capacity preventing consent
- •Surgical resection of any part of the intestine
- •Anticoagulation or dual antiplatelet use
- •Antibiotic use at time of enrolment
- •Contraindications to the use of prednisolone (e.g. poorly controlled Diabetes Mellitus, history of steroid-induced mental health complications such as depression, mania or psychosis)
- •Plans for travel from South Australia for >4 weeks during the 12 months study period
研究者
相似试验
已完成
3 期
Remission maintenance treatment of ulcerative colitis with tacrolimus in azathioprine-intolerant patients: a randomized comparative trial of 5-aminosalicylic acid (5-ASA) monotherapy versus 5-ASA and tacrolimus combination therapy.JPRN-UMIN000003785Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine80
招募中
不适用
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesUlcerative ColitisNL-OMON54471Radboud Universitair Medisch Centrum40
招募中
不适用
Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remissioulcerative colitisJPRN-UMIN000043098Sapporo Medical University150
已完成
不适用
Symptom improvement of ulcerative colitis after an induction dose of ustekinumab in Japanese clinical practice, measured using patient-reported outcomesJPRN-UMIN000043753Janssen Pharmaceutical K.K136
已完成
不适用
Histological remission in ulcerative colitis: comparing histological activity indexesUlcerative colitislcerative colitisDigestive SystemISRCTN61139227Radboud University Medical Center (Netherlands)50